Cargando…
Case report: Percutaneous adrenal arterial embolization cures resistant hypertension
BACKGROUND: Primary aldosteronism is a common cause of resistant hypertension. Patients with primary aldosteronism due to aldosterone-producing adenoma are generally treated with unilateral adrenalectomy or medical therapy. Superselective adrenal arterial embolization is an alternative treatment for...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592891/ https://www.ncbi.nlm.nih.gov/pubmed/36304542 http://dx.doi.org/10.3389/fcvm.2022.1013426 |
_version_ | 1784815032384618496 |
---|---|
author | Zhou, Yaqiong Wang, Dan Liu, Qiting Hou, Jixin Wang, Peijian |
author_facet | Zhou, Yaqiong Wang, Dan Liu, Qiting Hou, Jixin Wang, Peijian |
author_sort | Zhou, Yaqiong |
collection | PubMed |
description | BACKGROUND: Primary aldosteronism is a common cause of resistant hypertension. Patients with primary aldosteronism due to aldosterone-producing adenoma are generally treated with unilateral adrenalectomy or medical therapy. Superselective adrenal arterial embolization is an alternative treatment for patients with unilateral primary aldosteronism. CASE SUMMARY: We present a 39-year-old male patient with a 5-year history of primary aldosteronism and secondary hypertension. The patient refused adrenalectomy while accepted pharmacotherapy. Despite taking adequate dose of spironolactone, the patient experienced repeatedly muscle weakness due to hypokalemia and had poor blood pressure control with left ventricular hypertrophy and renal dysfunction. Aldosterone-producing adenoma in the left adrenal gland was confirmed by computerized tomography and adrenal venous sampling. The left middle adrenal artery, which was confirmed to provide the main arterial supply to the aldosterone-producing adenoma, was embolized by injecting 2 ml ethanol. The embolization normalized his blood pressure for up to 3 months and reversed left ventricular hypertrophy. CONCLUSION: Superselective adrenal arterial embolization could be an alternative treatment for patients with aldosterone-producing adenoma who refuse adrenalectomy. |
format | Online Article Text |
id | pubmed-9592891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95928912022-10-26 Case report: Percutaneous adrenal arterial embolization cures resistant hypertension Zhou, Yaqiong Wang, Dan Liu, Qiting Hou, Jixin Wang, Peijian Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Primary aldosteronism is a common cause of resistant hypertension. Patients with primary aldosteronism due to aldosterone-producing adenoma are generally treated with unilateral adrenalectomy or medical therapy. Superselective adrenal arterial embolization is an alternative treatment for patients with unilateral primary aldosteronism. CASE SUMMARY: We present a 39-year-old male patient with a 5-year history of primary aldosteronism and secondary hypertension. The patient refused adrenalectomy while accepted pharmacotherapy. Despite taking adequate dose of spironolactone, the patient experienced repeatedly muscle weakness due to hypokalemia and had poor blood pressure control with left ventricular hypertrophy and renal dysfunction. Aldosterone-producing adenoma in the left adrenal gland was confirmed by computerized tomography and adrenal venous sampling. The left middle adrenal artery, which was confirmed to provide the main arterial supply to the aldosterone-producing adenoma, was embolized by injecting 2 ml ethanol. The embolization normalized his blood pressure for up to 3 months and reversed left ventricular hypertrophy. CONCLUSION: Superselective adrenal arterial embolization could be an alternative treatment for patients with aldosterone-producing adenoma who refuse adrenalectomy. Frontiers Media S.A. 2022-10-11 /pmc/articles/PMC9592891/ /pubmed/36304542 http://dx.doi.org/10.3389/fcvm.2022.1013426 Text en Copyright © 2022 Zhou, Wang, Liu, Hou and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Zhou, Yaqiong Wang, Dan Liu, Qiting Hou, Jixin Wang, Peijian Case report: Percutaneous adrenal arterial embolization cures resistant hypertension |
title | Case report: Percutaneous adrenal arterial embolization cures resistant hypertension |
title_full | Case report: Percutaneous adrenal arterial embolization cures resistant hypertension |
title_fullStr | Case report: Percutaneous adrenal arterial embolization cures resistant hypertension |
title_full_unstemmed | Case report: Percutaneous adrenal arterial embolization cures resistant hypertension |
title_short | Case report: Percutaneous adrenal arterial embolization cures resistant hypertension |
title_sort | case report: percutaneous adrenal arterial embolization cures resistant hypertension |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592891/ https://www.ncbi.nlm.nih.gov/pubmed/36304542 http://dx.doi.org/10.3389/fcvm.2022.1013426 |
work_keys_str_mv | AT zhouyaqiong casereportpercutaneousadrenalarterialembolizationcuresresistanthypertension AT wangdan casereportpercutaneousadrenalarterialembolizationcuresresistanthypertension AT liuqiting casereportpercutaneousadrenalarterialembolizationcuresresistanthypertension AT houjixin casereportpercutaneousadrenalarterialembolizationcuresresistanthypertension AT wangpeijian casereportpercutaneousadrenalarterialembolizationcuresresistanthypertension |